Ozempic, Wegovy, other GLP-1RA drugs not linked to increased pancreatic cancer risk, study finds
Posted:
New research has concluded that drugs from the glucagon-like peptide-1 receptor agonists (GLP-1RA) class do not increase the risk of pancreatic cancer.
The VPodDuoss (the ‘V’ stands for virus)— can read and compare results from a variety of tests for pathogens or cancer-associated biomarkers.
It’s the brainchild of Lee, University of Illinois Urbana-Champaign Computer Engineering Professor Brian Cunningham, PhD, and Bioengineering Professor Xing Wang, PhD,…
Atherosclerosis, the process underlying most cardiovascular diseases, begins long before the first symptoms appear.
An international study led by Professor Henning Bundgaard, Professor of Cardiology at Rigshospitalet in Copenhagen, Denmark, and Dr Borja Ibáñez, Scientific Director of the Centro Nacional…
Attendees
Sponsors and Exhibitors
Contact us